Introduction: The purpose of this study is to test the efficacy potential of using real-time positive auditory feedback to improve gait pattern in people with Parkinson's Disease (PD). The components of walking are commonly affected in patients with PD. Gait training for PD is usually based on verbal cues from the therapist that are only moderately effective. Based on good principals of gait and neuroplasticity, the Heel-To-Toe (Heel2Toe) sensor was developed to provide real-time auditory feedback during walking training. Methods: A two-group, randomized feasibility trial is planned with repeated measures of gait parameters and walking outcomes. Participants will be assessed at baseline, 3 and 6 months. Outcomes after the 5 training days will be obtained directly from the Hee2Toe device for both groups (with and without auditory feedback). The primary outcome is walking capacity measured by the Six-Minute Walk Test and the Standardized Walking Obstacle Course. Gait parameters will be captured by the Heel2Toe device Expected Contributions: Gait training using the Heel2Toe sensor will be potentially effective for improving walking pattern in people with PD.
As this is a feasibility study, the main analysis will focus on within-group change over the intervention period of 3 months using indices of reliable change(36). This method assesses the number of people who changed in each of the groups based on the magnitude of change relative to pre-post variability and correlation. We will estimate the proportion of people with reliable change. Estimates from the pilot study will be used to plan the main trial if the pilot demonstrates feasibility. For the maintenance period, reliable change from baseline will also be estimated and used to identify the proportion of people who maintained reliable change or who gained/lost this status. The study is designed to detect a minimal important within-group change of moderate magnitude or greater (effect size ½ standard deviation) with adequate precision. A sample size of 20 in the intervention with completed follow-up will provide a 95% confidence interval with precision that excludes an effect size of 0.03.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
27
Heel to Toe (Heel2Toe) is a device that clips on the shoe and provides an instant auditory feedback (a beep) for each correct step characterized by putting the heel first and it provides data on gait parameters
The control group will follow the same protocol as the Heel2Toe group but the device will not be in feedback mode just in data acquisition mode.
McGill University Health Center
Montreal, Quebec, Canada
Reliable Change in Six-Minute Walk Test
Performance-rated outcome
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Change in Standardized Walking Obstacle Course (SWOC)
Performance-rated outcome of challenges experienced with starting, stopping, turning, making motor decisions. The metric is the time to complete a 12.2-m long, 0.92-m wide curved pathway, with obstacles commonly encountered in daily life.
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Safety (Falls)
Self-reported number of falls during study period
Time frame: Baseline to 3 months.
Technology acceptability (System Usability Scale)
Patient-reported outcome on satisfaction and intent-to-use
Time frame: 3 months (1 time point)
Change in Gait Quality (Data capture from Heel2Toe sensor)
Technologically-reported outcome
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)]
Change in Lower Extremity Function (Neuroqol)
Patient-reported outcome on degree of difficulty with activities related lower extremity function
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Change in Postural Instability and Gait Dysfunction (UPDRS)
Self-reported outcome of limitations
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Change in health-related quality of life (EQ-5D-3L)
Patient-reported outcome (EQ-5D-3L)
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Change in motivation (Starkstein Apathy Scale, Activity Effort Inventory)
Patient-reported outcome
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Change in health states (Visual Analogue Health States)
Patient reported outcome of 8 health states measured on 0 to 10 scale
Time frame: Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Cognitive performance (Symbol Digit Modality Test)
Performance-rated outcome
Time frame: Baseline, 3 months, 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.